Results for:(18 found)
Apr 1, 2014 12:57PM on Top StocksBy MSN Money Partner

Sales of the hepatitis C treatment Sovaldi are soaring, and insurance companies could see a double-digit cut to profits as a result.

Mar 3, 2014 1:54PM on Top StocksBy MSN Money Partner

Does the market recovery have what it takes to run further? This week could shed more light on the answer.

Aug 28, 2013 12:10PM on Top StocksBy Minyanville.com

Who's serving our youth-obsessed culture? Here's where to start your research.

Aug 21, 2013 3:28PM on Top StocksBy StreetAuthority

While investors often regard spinoffs as problem children, that stereotype doesn't fit this overlooked drugmaker. And you can profit from this.

Aug 12, 2013 10:09AM on Top StocksBy MSN Money Partner

Krispy Kreme is upgraded to 'buy,' and Juniper is downgraded to 'sector perform.'

Jul 29, 2013 4:00PM on Top StocksBy StreetAuthority

The current earnings season has given investors a fresh peek into names that are capable of much higher yields down the road.

Jul 29, 2013 7:14AM on Top StocksBy Benzinga

Data released over the weekend spooked investors and sent shares down.

Jun 12, 2013 11:31AM on Top StocksBy TheStreet Staff

Sales of the psoriatic arthritis drug could be in the billions as data indicate response rates increasing over time.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More